Diversity and Inclusion in Clinical Trials: Global and Regional Perspectives
Keywords:
Diversity and inclusion, clinical trials, underrepresentation, health equity, global health, ethical research, regulatory policy, inclusive medicine, evidence-based medicine, participant recruitmentAbstract
Clinical trials are the cornerstone of evidence-based medicine, yet persistent gaps in diversity and inclusion (D&I) threaten the generalizability, equity, and ethical integrity of medical research. Underrepresentation of racial, ethnic, gender, socioeconomic, and age groups may result in treatments that are ineffective or unsafe for certain populations. This paper presents a comprehensive analysis of D&I in clinical trials from global and regional perspectives. It explores the historical context, examines existing challenges and systemic barriers, and highlights emerging trends, regulatory developments, and community-driven initiatives aimed at improving representation. The discussion emphasizes the need for inclusive research practices to ensure that medical innovations are safe, effective, and equitable across all population groups. Future directions focus on strengthening policy frameworks, enhancing recruitment strategies, and fostering trust through culturally sensitive engagement.
Downloads
References
FDA. (2022). Drug Trials Snapshots Summary Report.
NIH. (2020). Inclusion Across the Lifespan Policy.
EMA. (2022). Guidance on Stratified and Subgroup Analysis.
WHO. (2021). Global Clinical Trials Transparency Initiative.
Sleigh, A., & Timbie, J. (2023). Equity in Clinical Trials: A Global Mandate. The Lancet Global Health.
Thomas, C. R. et al. (2021). Increasing Diversity in Clinical Trials. JAMA.
Knepper, T. C., & McLeod, H. L. (2018). When will clinical trials finally reflect diversity? Nature Reviews Drug Discovery.
Loree, J. M., Anand, S., Dasari, A., Unger, J. M., Gothwal, A., Ellis, L. M., & Varadhachary, G. R. (2019). Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018. JAMA Oncology.
Sheikh, A., et al. (2021). Improving diversity in clinical research: the case for mandatory reporting.
Ejiogu, N., Norbeck, J. H., Mason, M. A., Cromwell, B. C., Zonderman, A. B., & Evans, M. K. (2011). Recruitment and retention strategies for minority or poor clinical research participants: Lessons from the Healthy Aging in Neighborhoods of Diversity across the Life Span study.
Harrington, L., & Nash, R. (2022). Building inclusive clinical trials through community engagement and trust.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Scientific Research in Science and Technology
This work is licensed under a Creative Commons Attribution 4.0 International License.
https://creativecommons.org/licenses/by/4.0
